Innovation Pharmaceuticals Inc (IPIX)

[slcimmuno]

F1lash posted the SAE clarification --
ECCMID LINKS

PRESENTATION
Synthetic novel host defense protein mimetics for the treatment of Gram-negative bacterial infections. Speaker: Siya Ram, CTIX Director of Chemistry
http://eccmid.meetingexpert.net/ECCMID_546/poster_122353/program.aspx

PRESENTATION
A randomized, double blind study comparing single dose and short course Brilacidin to Daptomycin in treatment of ABSSSI. Speaker Daniel Jorgensen, CTIX Chief Medical Officer
http://eccmid.meetingexpert.net/ECCMID_546/searchPresentation.aspx?option=Presentation&page=1

POSTER
Brilacidin, host defence peptide mimetic, one of a new class of immunomodulatory agents that can target multiple disease indications
http://eccmid.meetingexpert.net/ECCMID_546/poster_121449/program.aspx

N8 Medical also there
http://eccmid.meetingexpert.net/ECCMID_546/poster_120899/program.aspx

And here are all the Daptomycin Posters/Presentations/Sessions
http://eccmid.meetingexpert.net/ECCMID_546/search.aspx?stext=Daptomycin&soption=All